Cargando…

Trans-myocardial Extraction of Endothelin-1 Correlates with Increased Microcirculatory Resistance following Percutaneous Coronary Intervention

OBJECTIVE: Coronary microvascular dysfunction (CMD) can complicate successful percutaneous coronary intervention (PCI). The potent endogenous vasoconstrictor peptide Endothelin-1 (ET-1) may be an important mediator. To investigate the mechanism, we sought to define the peri-procedural trans-myocardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abraham, George R., Nyimanu, Duuamene, Kuc, Rhoda E., Maguire, Janet J., Davenport, Anthony P., Hoole, Stephen P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553718/ https://www.ncbi.nlm.nih.gov/pubmed/36262459 http://dx.doi.org/10.1155/2022/9154048

Ejemplares similares

Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor
por: Nyimanu, Duuamene, et al.
Publicado: (2019)

Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19
por: Abraham, George R., et al.
Publicado: (2022)

In vitro metabolism of synthetic Elabela/Toddler (ELA-32) peptide in human plasma and kidney homogenates analyzed with mass spectrometry and validation of endogenous peptide quantification in tissues by ELISA
por: Nyimanu, Duuamene, et al.
Publicado: (2021)

Plasma levels of apelin are reduced in patients with liver fibrosis and cirrhosis but are not correlated with circulating levels of bone morphogenetic protein 9 and 10
por: Owen, Nicola E., et al.
Publicado: (2021)

Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites
por: Williams, Thomas L., et al.
Publicado: (2021)

Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney function
por: Nyimanu, Duuamene, et al.
Publicado: (2022)

The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo
por: Read, Cai, et al.
Publicado: (2021)

Development and validation of an LC-MS/MS method for detection and quantification of in vivo derived metabolites of [Pyr(1)]apelin-13 in humans
por: Nyimanu, Duuamene, et al.
Publicado: (2019)

The therapeutic potential of apelin in kidney disease
por: Chapman, Fiona A., et al.
Publicado: (2021)

Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension
por: Kuc, Rhoda E., et al.
Publicado: (2014)

Endothelin Receptors and Their Antagonists()()
por: Maguire, Janet J., et al.
Publicado: (2015)

A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension
por: Yang, Peiran, et al.
Publicado: (2019)

Mechanistic study of the effect of Endothelin SNPs in microvascular angina – Protocol of the PRIZE Endothelin Sub-Study
por: Abraham, George R., et al.
Publicado: (2022)

Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection
por: Williams, Thomas L., et al.
Publicado: (2021)

Endothelin
por: Davenport, Anthony P., et al.
Publicado: (2016)

Endothelin ET(A) receptors predominate in chronic thromboembolic pulmonary hypertension
por: Southwood, Mark, et al.
Publicado: (2016)

International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand
por: Read, Cai, et al.
Publicado: (2019)

Serial assessment of the index of microcirculatory resistance during primary percutaneous coronary intervention comparing manual aspiration catheter thrombectomy with balloon angioplasty (IMPACT study): a randomised controlled pilot study
por: Hoole, Stephen P, et al.
Publicado: (2015)

Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction
por: Ford, Thomas J, et al.
Publicado: (2020)

Association of Hyperhomocysteinemia with Increased Coronary Microcirculatory Resistance and Poor Short-Term Prognosis of Patients with Acute Myocardial Infarction after Elective Percutaneous Coronary Intervention
por: Peng, Yang-Pei, et al.
Publicado: (2020)

The CCR5 chemokine receptor mediates vasoconstriction and stimulates intimal hyperplasia in human vessels in vitro
por: Maguire, Janet J., et al.
Publicado: (2014)

Expanding the apelin receptor pharmacological toolbox using novel fluorescent ligands
por: Williams, Thomas L., et al.
Publicado: (2023)

Primary Percutaneous Coronary Intervention in a Patient with Haemophilia A
por: Reddy, S. Ashwin, et al.
Publicado: (2013)

Endothelin@25 – new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12
por: Maguire, J J, et al.
Publicado: (2014)

Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal Remodeling
por: Miller, Eileen, et al.
Publicado: (2017)

Evidence for biased agonists and antagonists at the endothelin receptors
por: Maguire, Janet J.
Publicado: (2016)

The Index of Microcirculatory Resistance after Primary Percutaneous Coronary Intervention Predicts Long-Term Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction
por: Yoon, Gwang-Seok, et al.
Publicado: (2021)

Cardiac action of the first G protein biased small molecule apelin agonist
por: Read, Cai, et al.
Publicado: (2016)

Index of Microcirculatory Resistance at the Time of Primary Percutaneous Coronary Intervention Predicts Early Cardiac Complications: Insights From the OxAMI (Oxford Study in Acute Myocardial Infarction) Cohort
por: Fahrni, Gregor, et al.
Publicado: (2017)

Inotropic Action of the Puberty Hormone Kisspeptin in Rat, Mouse and Human: Cardiovascular Distribution and Characteristics of the Kisspeptin Receptor
por: Maguire, Janet J., et al.
Publicado: (2011)

Invasive Evaluation of the Microvasculature in Acute Myocardial Infarction: Coronary Flow Reserve versus the Index of Microcirculatory Resistance
por: D. Clarke, John-Ross, et al.
Publicado: (2019)

The Impact of Trimethylamine N-Oxide and Coronary Microcirculatory Dysfunction on Outcomes following ST-Elevation Myocardial Infarction
por: Aldujeli, Ali, et al.
Publicado: (2023)

Targeting IL-36 improves age-related coronary microcirculatory dysfunction and attenuates myocardial ischemia/reperfusion injury in mice
por: El-Awaisi, Juma, et al.
Publicado: (2022)

Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR1), not G‐Protein‐Coupled Receptor 1 (GPR1), in Human and Rat Vasculature
por: Kennedy, Amanda J., et al.
Publicado: (2016)

Comprehensive assessment of microcirculation after primary percutaneous intervention in ST-segment elevation myocardial infarction: insight from thermodilution-derived index of microcirculatory resistance and coronary flow reserve
por: Park, Sang-Don, et al.
Publicado: (2016)

[Pyr(1)]Apelin-13((1–12)) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr(1)]Apelin-13
por: Yang, Peiran, et al.
Publicado: (2017)

Coronary flow reserve and microcirculatory resistance in patients with coronary tortuosity and without atherosclerosis
por: Li, Yang, et al.
Publicado: (2020)

Case of fulminant type 1 diabetes with coronary microcirculatory dysfunction
por: Yamada, Hodaka, et al.
Publicado: (2014)

Remote Ischemic Preconditioning Acutely Improves Coronary Microcirculatory Function
por: Lau, Jerrett K., et al.
Publicado: (2018)

Angiography-derived index of microcirculatory resistance as a novel, pressure-wire-free tool to assess coronary microcirculation in ST elevation myocardial infarction
por: De Maria, Giovanni Luigi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iclmhhgk9mqkcsirj2t8thnev0